홈
마켓
차트 & 아이디어
Algo
뉴스
스토어
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
히트맵
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
I
IHE
iShares U.S. Pharmaceutical ETF
92.0
1
USD
-0.68%
부문:
금융
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
-0.68%
월간 변동
+6.51%
6달 변화
+7.75%
년간 변동율
+43.01%
이전 종가
92.6
4
Open
92.7
4
저가
92.0
0
High
92.8
9
양
25
마켓
US ETFs
IHE
전체 차트 열기
Full chart
개요
모든 보유 자산
히트맵
주요 보유 종목
Market Value
Shares
Weight %
LQDA
Liquidia Corp
7.2 M
192.1 K
0.7%
EWTX
Edgewise Therapeutics Inc
6.5 M
207.1 K
0.7%
AMRX
AMNEAL PHARMACEUTICALS, INC.
5.9 M
474.5 K
0.6%
NKTR
NEKTAR THERAPEUTICS
5.6 M
78.2 K
0.6%
DFTX
Definium Therapeutics Inc
5.2 M
275.3 K
0.5%
ALMS
Alumis Inc
5.0 M
226.6 K
0.5%
ELVN
Enliven Therapeutics Inc
4.9 M
124.4 K
0.5%
INVA
INNOVIVA, INC.
4.6 M
198.5 K
0.5%
OGN
ORGANON & CO.
4.4 M
726.7 K
0.4%
PRGO
PERRIGO COMPANY PUBLIC LIMITED COMPANY
4.1 M
384.7 K
0.4%
OCUL
OCULAR THERAPEUTIX, INC.
4.1 M
486.8 K
0.4%
ANIP
ANI PHARMACEUTICALS, INC.
3.9 M
50.2 K
0.4%
TRVI
Trevi Therapeutics Inc
3.5 M
290.3 K
0.3%
HROW
HARROW, INC.
3.2 M
92.1 K
0.3%
AMLX
Amylyx Pharmaceuticals Inc
3.2 M
233.3 K
0.3%
PAHC
PHIBRO ANIMAL HEALTH CORPORATION
3.2 M
57.6 K
0.3%
HRMY
HARMONY BIOSCIENCES HOLDINGS, INC.
3.1 M
111.1 K
0.3%
WVE
WAVE Life Sciences Ltd
2.9 M
404.1 K
0.3%
COLL
Collegium Pharmaceutical, Inc.
2.9 M
88.4 K
0.3%
NUVB
Nuvation Bio Inc
2.9 M
668.8 K
0.3%
1
2
3
뉴스
Healthcare ETFs to Buy as Eli Lily Steps Into Vaccine Market With $4B Bet
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
While Everyone Chases AI, Pharma Keeps Getting Cheaper
IHE: Healthcare Dashboard For May
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
Defensive Stocks: A Potential Antidote To Inflation Shocks